Replies to post #11588 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[comet52]

Someone who can't bother with (or do) that analysis will just hang out here pumping all the time and spitting sarcasm at others who want to think critically about the company, I guess.

I thought the wench-in-the-thong hedgie pop would go to $1.80 or so, but it seems the general market pooping the other day kinda killed the mo-mo. It's eroding slowly, probably getting ready to slide back to $1.30 or so. But you never know what those crazy algos might do...

Maybe Conman Jonnie will save us with a thyroid study! To da Moon, Alice!!

[leifsmith]

I'm not in this based on current financials. I'm in this because anatabine suppresses the activation of NF-kB, and because anatabine is a MAO inhibitor (think about e-cigarettes) and because the company has good patent coverage. Current financials are not significant as long as sales keep rising and margins improve because of better sales / costs ratio.